Popit provides a smart medication adherence solution to help individuals track their medication intake and reduce missed doses. Self-described as developed with healthcare professionals, it offers features for users to monitor their medication history.

Popit

Click Therapeutics develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. Their Digital Therapeutics™ enable change within individuals through cognitive and neurobehavioral mechanisms, designed to be used independently or in conjunction with biomedical treatments.

Victor Gao

David Benshoof Klein

Click Therapeutics

HealthPrize provides digital health engagement programs aimed at improving patient adherence to treatment plans for individuals with chronic conditions, self-described as effective in enhancing health outcomes.

HealthPrize

A company that provides a remote patient monitoring platform for connected care and research acceleration.

Huma

Popit offers a smart pill tracking solution that helps users keep track of their medications to reduce missed doses.

Popit Ltd | 995 followers on LinkedIn. Popit makes medication connected. Validated to improve adherence and patient engagement, leading to healthier patients. | Popit is a pioneer in improving patient adherence through smart consumer devices. We are dedicated to improving adherence by digitizing medicine, a major opportunity that offers benefits for pharmaceutical companies and consumers alike.

Mobile Developer | Solution Architect | Scrum Master

Teemu Piirainen

Business Development Professional | Innovation Commercialization & Funding | B2B/B2C Sales & Marketing | Market Research & Analysis | Brought a…

Timo Heikkilä

Creating value to the pharmaceutical field

Mikko Veräjänkorva

Senior Designer at Fantasia Works Oy

Toni Ruotsalainen

Popit Ltd

Popit is collaborating in Japan with the IT giant NEC Corporation . Check out this recent interview by TECH+ on our partnership. Do read up also on the NEC Innovation Challenge, organized by NEC together with Agorize . This is how we got in touch with NEC so highly recommended! Timo Heikkilä Ikue Valovirta Mamoru Tsutsui

Popit is active also in South America. Check out our thoughts on the market in this Team Finland Latin America 's 1st ever newsletter with regional insights: https://lnkd.in/dHNVEA_C

#SuccessCase : Popit Ltd , a leading company in transforming the healthcare industry, has introduced an innovative solution in the Colombian market. This solution allows easy tracking of medication doses by patients and caregivers, revolutionizing healthcare management. Hear directly from the Co-founder and CEO, Timo Heikkilä , about the company's journey in this week's highlight interview 🇨🇴 🤝 🇫🇮 #HealthCareInnovation #Colombia #TeamFinland #BFinLatam Business Finland Roberto Requejo Heidi Virta Nicolás Vassallo Antti Kaski Ville Pennanen Terhi Kiviranta Rasmussen Renja Reyes Jalaskoski #SuccessCases

Team Finland Latin America

We could never have envisioned that our product would one day be exhibited in a museum. Yet, sometimes, the unexpected does occur. We are thrilled to announce that Popit is now part of the esteemed collection at Austria's Museum of Contraception and Abortion.😁 This museum is more than just a spot to show off our product; it's a deep dive into the wild world of contraception through the ages. You’ll find everything from brilliantly effective gadgets to some hilariously questionable contraptions (CocaCola? Really?), all while peering into the future of reproductive tech. Go check it out 👉 https://lnkd.in/djnWQkjg

Popit is at Arab Health 2024, a massive international health trade show attracting more than 50,000 visitors and over 3500 exhibitors. If you happen to be there also, and find Timo Heikkilä there, ask for a Popit demo! #arabhealth2024

Season's Greetings from Popit! 🎄 💕 We think that Santa MAYBE using Popit - because how else is he in such a top condition at 1743 years old 🤔 ? Be like Santa🎅 To our investors, customers and Popit users, we'd like to take a moment to express our deepest appreciation for the trust and confidence you have placed in us. THANK YOU! Merry Xmas and a Happy New Year to all ❤️

Let Slushy 2 days begin 🔥 Popit is attending Slush 2023! Feel free to reach out directly to Timo Heikkilä Teemu Piirainen or Ikue Valovirta !

Episode 62 from our sponsoring podcast, adhd-podi, is out! In this episode, the host invites Finnish actress Pirjo Lonka who was diagnosed with adhd at the age of 51. She tells about how her loved ones react to Pirjo's symptoms, and looking back, what childhood and adolescence look like for her now. Is it worth going through the diagnosis process while still in the turmoil of menopause? Truly unique insights here. Go and listen!

We’re thrilled that Popit has been featured in the AlbionVC European HealthTech Market Map 2023, which includes leading companies across the digital care and digital pharma in Europe. https://lnkd.in/e4BAJtf6

The new episode "Shame" ("Häpeä" in Finnish)is out on adhd-podi!! Popit is sponsoring adhd-podi, which is a Finnish, increasingly popular podcast focusing on neurodiversity. On this episode, the hosts, Ringa and Reetta, share their own and listeners' (including our own) shameful experiences and stories and give shamefully excellent tips with no judgement 😄 🙈 More info on their Instagram profile https://lnkd.in/dHBt382X #adhd #adhdawareness #neurodiversity #podcast

Metric
Company Name	Popit	Click Therapeutics	HealthPrize	Huma
Symbol
MSH ID	IO:POPIT	COM:CLICKTHERAPEUTICS	COM:HEALTHPRIZE	COM:HUMA
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Health Technology	Biotechnology	Health Technology	Digital Health
Country	FI		US
Stage
Employee Count		101	11
Website	popit.io	clicktherapeutics.com	healthprize.com	huma.com
LinkedIn	popit-ltd		healthprize
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic			37.17K
Web Traffic Growth			-0.72
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

POPI

IO:POPIT

Popit

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue